Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Promoter methylation and the detection of breast cancer.

Authors: Brooks, Jennifer; Cairns, Paul; Zeleniuch-Jacquotte, Anne

Published In Cancer Causes Control, (2009 Nov)

Abstract: Mammographic screening has been shown to reduce breast cancer mortality in women over the age of 50 years, and to a lesser extent in younger women. The sensitivity of mammography, however, is reduced in some groups of women. There remains a need for a minimally invasive, cost-effective procedure that could be used along side mammography to improve screening sensitivity. Silencing of tumor suppressor genes through promoter hypermethylation is known to be a frequent and early event in carcinogenesis. Further, changes in methylation patterns observed in tumors are also detectable in the circulation of women with breast cancer. This makes these alterations candidate markers for early tumor detection. In this paper, we review the current literature on promoter hypermethylation changes and breast cancer and discuss issues that remain to be addressed in order for the potential of these markers to augment the sensitivity of screening mammography. In general, studies in well-defined populations, including appropriate controls and larger numbers are needed. Further, focus on the optimization of methods of methylation detection in small amounts of DNA is needed.

PubMed ID: 19768562 Exiting the NIEHS site

MeSH Terms: Biomarkers, Tumor/genetics*; Breast Neoplasms/diagnosis*; Breast Neoplasms/genetics*; DNA Methylation/genetics*; Early Detection of Cancer; Female; Genes, Tumor Suppressor; Humans; Mass Screening/methods*; Promoter Regions, Genetic/genetics*

to Top